These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 779005)
1. The resistance of 150 Klebsiella and E. coli strains isolated from patients suffering from bacteriaemia. Brandberg A; Lindblom GB; Franzén C Scand J Infect Dis Suppl; 1976; (8):103-5. PubMed ID: 779005 [No Abstract] [Full Text] [Related]
2. [Sensitivity of Klebsiella to antibiotics. Study of 50 strains from cases of "extra" and "intrahospital" septicemia]. Trolin C; Schoutens E; Yourassowsky E Pathol Biol (Paris); 1973 Jun; 21(6):581-5. PubMed ID: 4581191 [No Abstract] [Full Text] [Related]
3. Trimethoprim/sulphamethoxazole resistance in Escherichia coli and Klebsiella spp. urinary isolates. Obaseiki-Ebor EE Afr J Med Med Sci; 1988 Sep; 17(3):175-9. PubMed ID: 2845759 [TBL] [Abstract][Full Text] [Related]
4. [Antibiotic susceptibility of E. coli strains isolated from urinary tract infections and the role of metabolically deficient strains in these infections]. Söyletir G; Günalp A Mikrobiyol Bul; 1985 Oct; 19(4):210-7. PubMed ID: 3913849 [TBL] [Abstract][Full Text] [Related]
5. Trimethoprim-resistant Enterobacteriaceae in urinary tract infection. Wong CK; Harding GK; Ronald AR; Hoban S Can Med Assoc J; 1975 Jun; 112(13 Spec No):54-8. PubMed ID: 1093652 [TBL] [Abstract][Full Text] [Related]
6. Resistance of urinary tract isolates of Escherichia coli to trimethoprim, cotrimoxazole and ampicillin. Bailey RR; Peddie BA N Z Med J; 1988 Apr; 101(844):216-7. PubMed ID: 3283613 [No Abstract] [Full Text] [Related]
7. [Antibiotic resistance rates of extended spectrum beta-lactamase producing Escherichia coli and Klebsiella spp. strains isolated from urinary tract infections in a private hospital]. Akyar I Mikrobiyol Bul; 2008 Oct; 42(4):713-5. PubMed ID: 19149097 [TBL] [Abstract][Full Text] [Related]
9. Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy. Lee J; Pai H; Kim YK; Kim NH; Eun BW; Kang HJ; Park KH; Choi EH; Shin HY; Kim EC; Lee HJ; Ahn HS J Antimicrob Chemother; 2007 Sep; 60(3):629-37. PubMed ID: 17599919 [TBL] [Abstract][Full Text] [Related]
11. [Antibiotic resistance of Escherichia coli. Importance of the resistance to trimethoprim-sulfamethoxazole]. Riou B; Richard C; Rimailho A; Coquin Y; Rottman E; Auzepy P Ann Med Interne (Paris); 1985; 136(5):412-5. PubMed ID: 3904566 [TBL] [Abstract][Full Text] [Related]
12. [In vitro sensitivity of human pathogens to the drug combination sulfamethoxazole-trimethoprim]. Lebek G; Wiedmer E Schweiz Med Wochenschr; 1971 Sep; 101(38):1385-90. PubMed ID: 4946735 [No Abstract] [Full Text] [Related]
13. [The sulfamethoxazole-trimethoprim combination 1st survey into its in vitro activity in brazzaville, Congo Results of 780 bacterial strains isolated at the National Laboratory and the General Hospital in a single year]. Yala F Bull Soc Pathol Exot Filiales; 1979; 72(3):198-204. PubMed ID: 400121 [TBL] [Abstract][Full Text] [Related]
14. Outcomes evaluation of patients with ESBL- and non-ESBL-producing Escherichia coli and Klebsiella species as defined by CLSI reference methods: report from the SENTRY Antimicrobial Surveillance Program. Bhavnani SM; Ambrose PG; Craig WA; Dudley MN; Jones RN; Diagn Microbiol Infect Dis; 2006 Mar; 54(3):231-6. PubMed ID: 16423491 [TBL] [Abstract][Full Text] [Related]
16. Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan. Brown PD; Freeman A; Foxman B Clin Infect Dis; 2002 Apr; 34(8):1061-6. PubMed ID: 11914994 [TBL] [Abstract][Full Text] [Related]
17. [Antibacterial activity in vitro and in vivo of the trimethoprim-sulphamethoxazole combination]. Renzini G; Ravagnan G; Bormioli P; D'Alessandro A Antibiotica; 1969 Dec; 7(4):250-68. PubMed ID: 5004706 [No Abstract] [Full Text] [Related]
18. Evaluation of risk factors for the acquisition of bloodstream infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in the intensive care unit; antibiotic management and clinical outcome. Cordery RJ; Roberts CH; Cooper SJ; Bellinghan G; Shetty N J Hosp Infect; 2008 Feb; 68(2):108-15. PubMed ID: 18063198 [TBL] [Abstract][Full Text] [Related]
19. [Sensitivity to sulfamethoxazole-trimethoprim of Escherichia coli isolated from claves (author's transl)]. Wierup M Nord Vet Med; 1974 Nov; 26(11):626-33. PubMed ID: 4615298 [No Abstract] [Full Text] [Related]
20. Prevalence and antimicrobial resistance patterns of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated from blood cultures in an Istanbul University Hospital. Koksal F; Ak K; Kucukbasmaci O; Samasti M Chemotherapy; 2009; 55(4):293-7. PubMed ID: 19521075 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]